Anove LogoAnove LogoExplAIn
MapsAI frontrunners
Back to Directory

OLYSENSE

by Odin Vision

AI Application
Low Confidence

OLYSENSE is Olympus's cloud-based AI platform for gastrointestinal endoscopy, used by gastroenterologists and endoscopy teams during procedures. A hub connected to the endoscopy tower sends the live video to the cloud for analysis and returns the results to the endoscopy monitor. In Europe it offers three apps: CADDIE, which detects suspected colorectal polyps during colonoscopy and characterises them (CADe and CADx); CADU, which highlights the areas of an image most likely to show dysplasia in Barrett's oesophagus; and SMARTIBD, which supports a Mayo-score assessment of ulcerative colitis activity. Olympus's US product page says the gastroenterologist is responsible for reviewing the suspected polyp areas and decides with their own judgement whether a polyp is present, and that the system does not replace a full patient evaluation. The software is made by Odin Vision (Odin Medical Ltd, London), an Olympus company. Neither company names the cloud provider or the region where video is processed.

Visit Website

Transparency Score

Weighted across four pillars · updated October 20, 2026

Overall grade
37% weighted
ABCDF
Model
—
Not yet assessed
Infrastructure
—
Not yet assessed

Capabilities

Polyp Detection
Polyp Characterisation
Barretts Dysplasia Detection
Ulcerative Colitis Scoring
Real Time Endoscopy Support

Vendor Information

Complete information about the vendor/provider of this AI application

Odin VisionView all products →
Odin Medical Limited(Trading as: Odin Vision)
Contact Information
odin-vision.com
info@odin-vision.com
Registered Address
74 Rivington Street, London, England, EC2A 3AY, GB

EU AI Act Provider Information

Verification Status:
Unverified
(Last verified: October 20, 2026)
Odin Medical Limited(Trading as: Odin Vision)
74 Rivington Street, London, England, EC2A 3AY, GB
info@odin-vision.com
Emergo Europe B.V.
Westervoortsedijk 60, Arnhem, NL
Compliance Documents
CE Marking: Certified
Notified Body: Berlin Cert GmbH(Cert: Z-23-016-S-IX-E)
Olympus's US OLYSENSE page says CADDIE is 'intended to assist the gastroenterologist in identifying suspected colorectal polyps only', is 'limited for use with standard white-light endoscopy imaging only', is not meant to replace a full patient evaluation, and is not intended for primary interpretation, diagnosis or treatment recommendations (https://content.medical.olympusamerica.com/olysense, read 2026-10-20; US labelling, where CADDIE is cleared for detection only). The launch release refers to the device manual for indications, contraindications, warnings and precautions (https://www.acnnewswire.com/press-release/english/102829/olympus-launches-olysense-cad/ai-in-the-us-and-europe, read 2026-10-20); the EU manual was not found online.
Compliance & Risk

Get insights into risk by running assessments on this AI application.

Work at Odin Vision? Claim this listing to correct or complete the data.

Added: October 20, 2026
Updated: October 20, 2026

Ready to manage AI applications?

Track, assess, and govern your AI applications with Anove.

Anove LogoAnove LogoAnove International B.V.

Helping organizations discover and manage AI applications responsibly. Your trusted source for AI governance and compliance.

Quick Links

  • Browse Directory
  • FAQ
  • AI maps by industry
  • Sign In

Resources

  • Documentation
  • Status
  • Anove.ai

Terms

  • Privacy Policy
  • Terms & Conditions
  • Responsible Disclosure
  • AI Legal Notice
  • Security Policy

© 2026 Anove International B.V. All rights reserved.